1. The impact of the war in Ukraine on the prevalence of MDR/RR-TB in Poland.
- Author
-
Nowinski A, Augustynowicz-Kopeć E, Garnczarek J, Halicka A, Koszela M, Litwiniuk W, Maj D, Mazur I, Niestrój-Ostrowska J, Podlasin R, Regulska A, Wielopolska M, Wyrwiński J, Wesołowski S, and Korzeniewska-Koseła M
- Abstract
Background: The 2022 invasion of Ukraine by the Russian Federation triggered a refugee crisis, affecting the multidrug-/rifampicin-resistant TB (MDR/RR-TB) prevalence in neighbouring countries. This study examines the epidemiological trends and characteristics of MDR/RR-TB patients in Poland, focusing on the relative contribution of Ukrainian refugees., Methods: Data from the Polish National Tuberculosis Registry and EPIC Project database, covering MDR/RR-TB cases reported between 2010 and Q1 2024, were analysed., Results: The study included 794 MDR/RR-TB cases, showing a demographic shift post-2022. During the 10-year period up to 2021, a median of 48 MDR/RR-TB cases were reported annually in Poland. After 2022, these numbers doubled: 104 cases were reported in 2022 and 101 cases in 2023. Simultaneously, the number of Ukrainian MDR/RR-TB patients increased from 77 (13%) during 2010-2021 to 127 (58%) from 2022 to Q1 2024., Conclusion: Poland is observing an increased number of cases of MDR/RR-TB associated with the large number of displaced Ukrainian citizens who are now residing in Poland. There is a need to monitor the epidemiology of MDR/RR-TB and seek optimal screening and management strategies for TB among refugees from countries with high MDR/RR-TB incidence in Poland and Europe., (© 2025 The Authors.)
- Published
- 2025
- Full Text
- View/download PDF